MNTA Major Shareholders
[Updated for SEC filings through 6/22/10.]
The table below shows all shareholders who file Form 13G and
all insiders with a 1%+ stake on a fully-diluted basis (based on
49.1M diluted shares: #msg-42163809). Insider holdings include
restricted stock and options, whether or not vested. Non-insider
holdings other than Novartis are as of 12/31/09 unless otherwise
indicated in the table footnotes. (As a 10% owner on an SEC
reporting basis, Novartis’ filing requirements are the same
as those of insiders.)
Shares Stake
Novartis 4,708,679 9.6%
T Rowe Price 4,520,273 9.2%
BlackRock Inc. 2,782,260 5.7%
Visium Asset Mgmt 2,307,096† 4.7%
Samana Capital 2,048,303 4.2%
Craig Wheeler (CEO) 1,145,469 2.4%
G. Venkataraman (SVP, R&D) 631,315 1.3%
Ram Sasisekharan (Director) 507,344 1.0%
†As of 1/22/10 (from 13G filing 1/29/09).